FluoroPharma Medical, Inc. (FPMI) Appoints Thijs Spoor to Chairman of the Board
FluoroPharma Medical, a company specializing in the development of novel diagnostic imaging products that utilize positron emission tomography (PET) technology for the detection and assessment of disease before clinical manifestation, today after the closing bell announced that it has appointed Thijs Spoor to the position of Chairman of the Board. Mr. Spoor will also continue to hold the positions of President and CEO as he assumes the role formerly held by Dr. David Elmaleh. Mr. Spoor was appointed President and CEO of FluoroPharma Inc. on September 15, 2010. Prior to joining the company, he was the CFO of Sunstone BioSciences.…